Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;69(6):1563-1568.
doi: 10.4103/ijo.IJO_310_21.

Rise of the phoenix: Mucormycosis in COVID-19 times

Affiliations

Rise of the phoenix: Mucormycosis in COVID-19 times

Swati A Ravani et al. Indian J Ophthalmol. 2021 Jun.

Abstract

Purpose: Rhino-orbital mucormycosis in times of ongoing COVID-19 pandemic.

Aims: The aim of the study was to document cases of rhino-orbital mucormycosis seen at our Regional Institute of Ophthalmology during COVID-19 (coronavirus disease 2019) times.

Methods: The study is a retrospective, institutional cohort, interventional study. It was carried out at our Regional Institute of Ophthalmology from September 2020 to mid-March 2021. All patients of biopsy-proven mucormycosis were enrolled in the study. The patients were subjected to complete history taking, ophthalmological examination, and imaging studies. The patients were treated via a multidisciplinary approach with intravenous liposomal amphotericin B and debridement of local necrotic tissue. Exenteration was done when indicated. A minimum 75-day follow-up period was accorded to all study patients. Statistical analysis was done using Chi-square test. A P value ≤0.05 was taken as significant.

Results: Thirty-one patients were seen, with a mean age of 56.3 years. The major risk factors included uncontrolled diabetes (96.7%) and COVID-19 positivity (61.2%), with concomitant steroid use in 61.2% patients. The most common presentation was diminution of vision (<6/60 in 80.64% patients) and ophthalmoplegia (77.4%). The most common imaging findings were orbital cellulitis (61.29%) and pansinusitis (77.4%). Intravenous liposomal amphotericin B was given to all patients for an average 18.93 days. Exenteration was required in (n = 4) 12.9% of cases. Twenty-eight patients recovered and were alive on follow-up. Mortality was seen in three patients. The presence of cerebral involvement and a HbA1c value of ≥8 were found to be significant in the prediction of survival of patients with mucormycosis.

Conclusion: We present the largest institutional cohort of rhino-orbital mucormycosis patients during the ongoing COVID-19 pandemic era from our unique perspective.

Keywords: COVID-19; pandemic; rhino-orbital mucormycosis.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
A 58-year-old male diabetic, hypertensive post-COVID-19 with history of steroid therapy presented with OS total ophthalmoplegia, boil on lower lid, and chemosis
Figure 2
Figure 2
MRI of the patient shows OS orbital cellulitis, pansinusitis, and focal cerebritis
Figure 3
Figure 3
A panoramic view of the various clinical presentations of mucormycosis

Comment in

References

    1. Rootman J, Robertson W, Lapointe JS. Inflammatory diseases. In: Rootman J, editor. Diseases of the Orbit. A Multidisciplinary Approach. 1st ed. J. B. Lippincott Company; 1988. pp. 155–6.
    1. Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: A clinical and diagnostic perspective from China. Mycopathologia. 2020;185:599–606. - PMC - PubMed
    1. Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol. 2021;69:244–52. - PMC - PubMed
    1. Mehta S, Pandey A. Rhino-Orbital mucormycosis associated with COVID-19. Cureus. 2020;12:e10726. doi: 10.7759/cureus.10726. - PMC - PubMed
    1. Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, et al. Acute invasive Rhino-Orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthalmic Plast Reconstr Surg. 2021;37:e40–80. doi: 10.1097/iop. 0000000000001889. - PMC - PubMed

Substances